摘要：<p><strong>Introduction:</strong></p><p> </p><p>The World Health Organization in March 2020 announced a pandemic of COVID-19 disease caused by the SARS-CoV-2 virus. It is one of the seven species known to be pathogenic to humans in this group of viruses. The incubation period of the virus is 2-14 days, usually about 5 days. SARS-CoV-2 uses the ACE2 receptor to enter the host's mucosa and cause an active infection. Symptomatic infection may be complicated by reversible or irreversible changes in the lungs and pulmonary embolism.</p><p> </p><p><strong>Method:</strong><strong></strong></p><p> </p><p>Recent literature was reviewed based on PubMEd, Google scholar, using words: covid lung, post covid lung, post covid, covid lung fibrosis,</p><p> </p><p><strong>Objective: </strong></p><p>Systematisation of information on pulmonary postovid complications</p>
